ACE2 and COVID-19: Our hypothesis is that the furin protease-dependent cleavage of the SARS-CoV-2 spike protein and release of the circulating S1 subunit protein amplify ACE2 downregulation and subsequent Ang II production, thereby promoting neurological disorders seen in COVID-19 patients.